İnterlökinlerin biyolojik etkileri
Sitokinler, etkin monosit, makrofaj, lenfosit ve diğer hücreler tarafından üretilen peptid veya glikoprotein yapısında düzenleyici moleküllerdir. Bağışıklık veya yangısel olaylarda görev yapan hücrelerin etkinliklerini artıran sitokinler, etkilerini sistemik veya lokal olarak gösterirler. Sitokinler; interlökinler. interferonlar. koloni stimiilan faktörler ve çeşitli büyüme faktörleri gibi molekül gruplarından oluşmaktadır. Bu derlemede interlökinlerin biyolojik etkileri hakkında bilgi verilmiştir
The biological effects of interleukıns
Cvtokines are regülatör}’ molecules in structures of peptide and glvcoprotein produced bv activated monocyte, macrophage, lymphocyte and the other cells. Cvtokines increase cells functioning in immunity and inflammatory proccss and their effects are local or systemic. Cvtokines include groups of molecules such as interleukins, interferons, colony stimulating factors and a varietv of growth factors. In this review. current knowledge about the biological effects of interleukins has been given
___
- 1. Trotta PP: Cytokines: An Overview. Anı J Repro
Immunol 25:137-141,(1991).
- 2. Akyol G, Şengil, Z, Baysal B:İnterlökinler. S Ü
Tıp Fak Derg 10:117-123,(1994).
- 3. Arda M, Minbay A, Aydın N, Akay Ö, İzgür M.
Diker KS: İmmünoloji, Medisan Yayınevi.
Medisan Yayın Serisi No: 13. Ankara. (1994).
- 4. Abbas AK. Lichtman AH. Pober JS: Cellular and
molecular immunology: Philadelphia: W.B.
Saunders Company. (1991).
- 5. Szelenyi J: Cytokines and the Central nervous
system. Brain Res Bull 54:329-338, (2001).
- 6. Stein RC, D a 1 g 1 e i s h AG:
Immunomodulatory agents: The cytokines. Euro J
Cancer 30A: 400-404. (1994).
- 7. Rees RC: Cytokines as biological response
modifıers. J Clin Pathol 45: 93-98, (1992).
- 8. Dunn AJ. Wang J, Ando T: Effects of cytokines
on cerebral neurotransmission. Adv Exp MedBiol
461:117-127.(1999).
- 9. Imura H. Fukata J, Mori T: Cytokines and
endocrine funetion: An interaetion between the
immune and neuroendocrine Systems. Clin
Immunol35:107-115,(1991).
- 10. Grimble R: Inflammation. cytokines and nutrition.
Euro J Clin Nutr 45:413-417. (1991).
- 11. Smith KA: Interleukin-2.inception, impact and
implication. Science 240: 1169-1176. (1988).
- 12. Lindemann A. Mertelsmann R: Interleukin-3:
Structure and funetion. Cancer Invest 11:609-
623.(1993).
- 13. Gessner A, Rollinghoff M: Biologic funetions and
signalling of the interleukin-4 receptor complexes.
Immunobiology 201: 2 8 5-3 07. (2000).
- 14. LorentzA. Bischoff SC: Regulation of human
intestinal mast cells by stem celi factor and IL-4.
Immunol Rev 179:57-60. (2001).
- 15. Babiuk LA. Sordillo MC. Hughes HPA. RossiCampos A. Harlan R: Symposium:
Immunobiology of cytokines and their application
in disease prevention in dairy cattle. 74: 4385-
4398.(1991).
- 16. Oswald IP. Grazzinelli RT. Sher A. James SL: IL10 synergies with IL-4 and transforming growth
factor-beta to inhibit maerophage cytotoxic
aetivity. J Immunol 148: 3578-3585.(1992).
- 17. Mahanty S. Nutman TB: The biology of
interleukin-5 and its receptor. Cancer Invest 11:5.
624-634.(1993).
- 18. Lalani T. Simmons RK. Ahmed AR: Biology of
IL-5 in health and disease. Ann Allergy Asthma
Immunol 82:317-332. (1999).
- 19. Fujisawa T. Abu-Ghazaleh R. Kita II, Sanderson
CJ. Gleich GJ: Regulatorv effect of cytokines on
eosinophil degranulation. J Immunol 144:642-
646.(1990).
- 20. Yokota T. Coffman RL. Hagiawara H. Rennick
DM. Takebe Y. Yokota K. Gemmell L. Shrader B.
Yang G. Meverson P. Luh J. Hoy P. Pene J, Briere
F. Spits H. Bancherua J. de Vries J. Lee FD. Arai.
N. Arai. K: Isolation and characterisation
lymphokine cDNA elones encoding mouse and
human IgA-enhancing factor and eosinophil
colonu-stimulating factor activities: relationship to
interleukin 5. Proc Natl Acad Sci USA 84: 7388-
7398.(1987).
- 21. Bischoff SC. BrunnerTL. De WeckAL. Dahinden
CA: interleukin 5 modifies histamine release and
leukotıiene generation by human basophils in
response to diverse agonists. J Exp Med 172:1577-
1582.(1990).
- 22. Kishimoto T, Akira S. Taga T: Interleukin-6 and
its receptors. Science 258: 593- 597.(1992).
- 23. Barkhudaryan N, Dunn AJ:
Molecularmechanisms of actions of interleukin-6 on
the brain. with special reference to serotonin and the
hypothalamo-pituitary-adrenocortical axis. Neurochem Res 24:1169-1180.(1999).
- 24. Revel M: Interleukin-6. “Powanda M
(Ed): Monokines and other non-lymphocytic
cytokines”. Liss. (1988).
- 25. LotzM: Interleukin-6. Cancer Invest 11:
732-742.(1993).
- 26. Barton BE: The biological effects of
interleukin 6. Med Res Rev 16: 87-109. (1996).
- 27. Frei K. Malipiero UV. Leist TP,
Zinkernagel RM. Schwab ME. Fontana A: On the
cellular source and function of interleukin 6 produced
in the Central nervous system in viral diseases. Euro J
Immunol 19:689-694. (1989).
- 28. Appasamy PM: İnterleukin 7: Biology
and potential clinical applications. Cancer Invest
11:487-499.(1993).
- 29. Hickınan CJ. Crim JA. Mostowski HS:
Regulation of human cytotoxic T lymphocyte
development by IL-7. J Immunol 145: 2415-2420.
(1990).
- 30. Alderson MR, Tough TW Ziegler SF:
Interleukin/induces cvtokine secretion and tumoricidal
activity by human peripheral blood monocytes. J Exp
Med 173: 923-930. (1991).
- 31. Hebert CA. Baker JB: Interleukin-8: A
review. Cancer Invest 11:743-750,(1993).
- 32. Frew AJ: Cytokines, chemokines. T cells
and allergy. Clin Exp Allergv 26:2-4, (1996).
- 33. Sherry B. Cerami A: Small cvtokine
superfamily. Curr Opin Immunol 3: 56-60. (1991).
- 34. Quesniaux VFJ: Interleukins 9. 10. 11
and 12 and kit ligand: A brief overview. Res Immunol
143:385-400.(1992).
- 35. Renauld JC. Houssiau F, Louahed J,
Vink A. Van Snick J. Uyttenhove C: Interleukin-9.
AdvImmunol 54: 79-97.(1992).
- 36. Fiorentino DF. Bond MW. Mosmann
TR: Two types of mouse T helper celi. IV. Th2 clones
secrete a factor that inhibits cytokine production by
Thl clones. J Exp Med 170: 2081- 2095,(1989).
- 37. Lalani I, Bhol K. Ahmed AR:
interleukin-10: Biology. role in inflammation and
autoimmunity. Ann Aller Asthma Immunol 79:469-
483.(1997).
- 38. MacNeil IA, Suda T, Moore KW, Mosman
TR. Zlotnik. A: IL-10. a novel growth factor for
mature and immalure T cells. J Immunol 145:4167-
4173,(1990).
- 39. 39.Shelburne CP. Rvan JJ: The role of Th2
cytokines in mast celi hoıneostasis. Immunol Rev
179:82-93.(2001).
- 40. Leng SX. Elias JA: interleukin-11. Inter
J Biochem Celi Physiol 29: 1059-1062. (1997).
41. Yang YC: interleukin ll:an overview.
StemCells 11:474-486.(1993).
- 42. Qesniaux VF. Mayer P. Liehl E.
Goldman SJ. Fagg B: Review of a novel hematopoietic
cytokine. interleukin-11. Int Rev Exper Pathol 34 Pt A:
205-214.(1993).
- 43. Baumann H. Schendel P: interleukin-11
regulates the hepatic expression of the same plasma
protein genes as interleikin-6. J Biol Chem 266:
20424-20427.(1991).
- 44. Gately MK. Wolitzky AG. Quinn PM,
Chizzonite R: Regulation of human cytolvtic
lymphocyte responses by interleukin-12. Celi Immunol
143:127-142.(1992).
- 45. Chung F: Anti-inflammatory cytokines
in asthma and allergy: interleukin-10. interleukin- 12.
interferon-gamma. Mediators İnflamm 10: 51-
59.(2001).
- 46. Trinchieri. G Gerosa F:
Immunoregulation by interleukin-12. J Leukocyte Biol
59: 505-511.(1996).
- 47. Kobayashi M, Fitz L. Ryan M. Hewick
RM. Clark SC, Chan S. Loudon R. Sherman F.
Perussia B. Trinchieri G: Identification and
purifıcation of natural killer celi stimulatory factor
(NK.SF). a cytokine with multiple biologic effects on
human lymphocytes. J Exp Med 170: 827-845, (1989).
- 48. De-Wall Malefvt R. Figdor R, De-Vries
JE: Effects of interleukin 4 on monocyte functions:
comparison to interleukin 13. Res Immunol 144: 629-
633.(1993).
- 49. De -Vries JE: The role of İL-13 and its
receptor in allergy and inflammatory responses. J Aller
Clin Immunol 102:165-169,(1998).
- 50. Perera LP: Interleukin-15: it's role
ininflammation and immunity. Arch Imnıunol
Ther Exp (Warsz) 48:457-464. (2000).